Enbrel, Remicade safety updates slated for FDA panel

On Aug. 17, the FDA's Arthritis Advisory Committee will discuss safety updates for Enbrel etanercept, a soluble TNF inhibitor from Immunex (IMNX), and Remicade infliximab, an anti-TNF chimeric monoclo...